Fractyl Health announced today that it commercially launched its Revita DMR system for diabetes reversal in Germany.
Dexcom (Nasdaq:DXCM) today unveiled its upcoming Super Bowl commercial that announces the U.S. launch of its next-generation ...
Glooko announced today that it received ISO 27001 certification for its data management and remote patient monitoring ...
Know Labs (NYSE:KNW) announced that it entered into a series of strategic partnerships as it looks to move toward a major ...
Ten months after spinning off from BD, Embecta CEO Dev Kurdikar lays out what the future holds for the diabetes technology ...
Vero Biotech said in a news release that Genosyl is now the first and only iNO delivery device approved for rebreathing and ...
Pharmapack Europe today announced that Owen Mumford Pharmaceutical Services received one of its 2023 Pharmapack Awards.
Aptar Pharma announced today that it launched its first metal-free, multidose nasal spray pump, called the APF Futurity.
Vida Health announced that a study of its digital health diabetes management program demonstrated improvements in multiple ...
Koru Medical Systems announced that it entered into a development agreement with a maker of subcutaneous immunoglobulin ...
Fractyl Health announced today that six-month data from a study of its diabetes reversal tech demonstrated improvements in ...
Nemaura Medical (Nasdaq:NMRD) announced that it received a purchase order for 5,000 proBeat glucose sensor subscriptions.